Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Azurrx Biopharma, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Azurrx Biopharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Azurrx Biopharma, Inc. since 2005.
The reporting company's ticker symbol is AZRX. The reporting company's CIK number is 1604191.
The total value of stock buying since 2005 is $726,853.
The total value of stock sales since 2005 is $520,000.
The total value of stock option exercises since 2005 is $90,000.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-31||Ross Edmund Burke Jr.||Buy||23,848||1.12||26,709|
|2018-12-28||Ross Edmund Burke Jr.||Buy||29,575||1.18||34,898|
|2018-12-28||Shenouda Maged (CHIEF FINANCIAL OFFICER)||Buy||20,000||1.31||26,220|
|2018-12-28||Spoor Johan M. (PRESIDENT AND CEO)||Buy||38,583||1.29||49,964|
|2018-12-28||Casamento Charles J||Buy||9,000||1.41||12,690|
|2018-12-27||Ross Edmund Burke Jr.||Buy||66,122||1.16||76,370|
|2018-05-02||Ross Edmund Burke Jr.||Buy||20,000||2.50||50,000|
|2018-01-11||Borkowski Edward||Option Ex||36,000||2.50||90,000|
|2017-06-05||Ross Edmund Burke Jr.||Buy||128,572||3.50||450,002|
Insider trading activities including stock purchases, stock sales, and option exercises of AZRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Azurrx Biopharma, Inc. (symbol AZRX, CIK number 1604191) see the Securities and Exchange Commission (SEC) website.